ArticleTranslational animal science2026
Effect of single implant and re-implant strategies on growth performance and carcass characteristics in finishing cattle.
Article in Translational animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three randomized complete block design experiments evaluated a single implant strategy versus approved re-implant strategies in feedlot cattle using trenbolone acetate (TBA) and estradiol-based implants. Revalor implants were from Merck Animal Health; Synovex implants were from Zoetis. Exp. 1: A total of 1400 steers (initial BW = 320 kg), housed in open lot, dirt-surfaced pens with a concrete apron, were assigned to either a single Revalor-XS (initial 80 mg TBA + 16 mg E2; delayed 120 mg TBA + 24 mg E2) administered 209 d pre-harvest (XS) or a re-implant strategy of Synovex-Choice (100 mg TBA + 14 mg EB) on d 0 followed by Synovex-ONE Feedlot (200 mg TBA + 28 mg EB) 60 d later (CHSOF). Pen served as the experimental unit. Initial BW differed and was included as a covariate. CHSOF increased (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.